EYE
What one share of National Vision Holdings holds
Ophthalmic Goods
National Vision Holdings, Inc., a Delaware corporation, and its consolidated subsidiaries are referred to here as “we,” “our,” “us,” “the Company,” or “National Vision.” National Vision Holdings, Inc. conducts substantially all of its activities through its indirect, wholly-owned subsidiary, National Vision, Inc.
National Vision Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-04; the balance sheet is as of 2026-07-04.
| Sales | $25.02 |
|---|---|
| Profit | $0.62 |
| Capex (buildings and equipment) | $0.99 |
| Free cash flow | $0.60 |
| Cash and investments | $0.46 |
| Debt | $2.95 |
| Book value | $11.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $20.99 | $0.23 | $1.58 | $0.13 | — | $7.11 |
| 2017 | $22.17 | $0.70 | $1.50 | −$0.05 | — | $8.77 |
| 2018 | $19.44 | $0.30 | $1.32 | $0.03 | — | $9.51 |
| 2019 | $21.11 | $0.40 | $1.24 | $0.78 | — | $9.74 |
| 2020 | $20.68 | $0.44 | $0.93 | $1.91 | — | $11.16 |
| 2021 | $21.63 | $1.43 | $0.99 | $1.70 | — | $11.38 |
| 2022 | $20.48 | $0.52 | $1.41 | $0.07 | — | $11.41 |
| 2023 | $22.35 | −$0.84 | $1.46 | $0.74 | — | $10.59 |
| 2024 | $23.20 | −$0.36 | $1.22 | $0.49 | — | $10.36 |
| 2025 | $24.67 | $0.37 | $0.90 | $0.91 | — | $10.95 |